Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus
Clinical trial NCT03618056 · COMPLETED
Trial details
- NCT number
- NCT03618056
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2020-07-17
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.